Holen Sie sich die Stockscreener-App
331.50
0.22%
0.1975
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$331.70
Offen:
$332.99
24-Stunden-Volumen:
332.48K
Relative Volume:
0.13
Marktkapitalisierung:
$179.06B
Einnahmen:
$37.30B
Nettoeinkommen (Verlust:
$7.80B
KGV:
23.05
EPS:
14.3793
Netto-Cashflow:
$8.60B
1W Leistung:
+2.65%
1M Leistung:
-5.30%
6M Leistung:
-1.78%
1J Leistung:
+25.04%
1-Tages-Spanne:
$330.10
$334.19
1-Wochen-Bereich:
$320.52
$334.19
52-Wochen-Spanne:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
331.60 | 179.12B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
989.14 | 845.77B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
221.68 | 532.77B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
203.81 | 356.49B | 62.82B | 3.60B | 19.98B | 2.0274 |
AZN
Astrazeneca Plc
|
184.74 | 283.57B | 60.48B | 10.40B | 8.05B | 3.3297 |
NVS
Novartis Ag Adr
|
146.20 | 278.64B | 54.66B | 13.58B | 16.05B | 7.0171 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Hold |
| 2026-03-10 | Eingeleitet | Jefferies | Hold |
| 2026-02-20 | Eingeleitet | Barclays | Equal Weight |
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
AMGN Fairly Valued by DCF at $292 - GuruFocus
Amgen stock (US0311621009): Pharma giant navigates C-suite transition and Q1 growth - AD HOC NEWS
Swiss Life Asset Management Ltd Reduces Stake in Amgen Inc. $AMGN - MarketBeat
Amgen stock (US0311621009): $300M Puerto Rico investment signals manufacturing expansion - AD HOC NEWS
Amgen stock (US0311621009): Biotech leader navigates patent cliffs and pipeline momentum - AD HOC NEWS
Nicholas Company Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Securian Asset Management Inc. - MarketBeat
Amgen’s New Puerto Rico Biologics Investment Might Change The Case For Investing In Amgen (AMGN) - simplywall.st
Merck, Amgen double down on bad cholesterol to vanquish number 1 killer - BioSpace
Will FDA-Backed Real-Time Trials in SCLC Reframe Amgen's (AMGN) R&D Narrative? - Yahoo Finance
Amgen’s Real Time FDA Trial Pilot Puts Oncology Execution In Focus - Yahoo Finance
NewEdge Wealth LLC Acquires 7,521 Shares of Amgen Inc. $AMGN - MarketBeat
Why (AMGN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis - Amgen
Inside Amgen’s Next-Generation Labs: Powering Faster, Smarter Small Molecule Drug Discovery - Amgen
Amgen Q1 2026 slides: six growth drivers fuel 24% expansion By Investing.com - Investing.com Nigeria
Earnings call transcript: Amgen Q1 2026 beats EPS forecast, stock dips - Investing.com Nigeria
Amgen Q1 2026 slides: six growth drivers fuel 24% expansion - Investing.com
Amgen Inc. stock (US0311621009): U.S. manufacturing push and Q1 2026 results in focus - AD HOC NEWS
Amgen Inc. $AMGN Shares Acquired by Wesbanco Bank Inc. - MarketBeat
Amgen Inc. stock (US0311621009): Biotech giant eyes growth amid patent cliffs and pipeline bets - AD HOC NEWS
Crossmark Global Holdings Inc. Has $15.62 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Ethic Inc. Boosts Stock Position in Amgen Inc. $AMGN - MarketBeat
Is It Time To Reassess Amgen (AMGN) After A Steady Share Price And Strong DCF Case - simplywall.st
Is Amgen Stock Poised for a Rally? - Trefis
2 Dividend Stocks to Double Up On Right Now - The Motley Fool
Amgen Halts Phase 2 HZN-1116 Trial in Sjögren’s: What Investors Should Know - TipRanks
FY2026 EPS Estimates for Amgen Boosted by Erste Group Bank - MarketBeat
Amgen Inc. Stock (US0311621009): Shares Dip After Strong Q1 2026 Earnings Beat and Analyst Downgrade - AD HOC NEWS
Amgen Inc. stock (US0311621009): Rating upgrade and Q1 beat amid tax and regulatory overhangs - AD HOC NEWS
Amgen (NASDAQ:AMGN) Stock Rating Upgraded by Freedom Capital - MarketBeat
Generali Asset Management SPA SGR Raises Stake in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) EVP James Bradner granted RSUs, options; 407 shares withheld for taxes - Stock Titan
[Form 4] AMGEN INC Insider Trading Activity - Stock Titan
Amgen (AMGN) VP Matthew Busch granted RSUs and options, small tax share withholding - Stock Titan
Amgen (NASDAQ: AMGN) EVP gets major equity grants and tax share withholding - Stock Titan
Amgen (NASDAQ: AMGN) SVP receives RSU grant and 3,167 stock options - Stock Titan
Amgen (NASDAQ: AMGN) SVP receives 3,266 options and 500-share award - Stock Titan
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Amgen (NASDAQ: AMGN) EVP Reese awarded RSUs, stock options and withholds shares for taxes - Stock Titan
Amgen (NASDAQ: AMGN) EVP receives RSUs, options and tax-withheld shares - Stock Titan
Amgen finance and R&D chiefs will speak in a public webcast May 13 - Stock Titan
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE - PR Newswire
Amgen Stock Falls Despite Strong Earnings: What's Driving the Decline? - MarketWise
Freedom Capital Markets Initiates Amgen(AMGN.US) With Buy Rating, Announces Target Price $375 - Moomoo
Amgen stock rating upgraded to buy at Freedom Broker on growth - Investing.com
Swedbank AB Cuts Stake in Amgen Inc. $AMGN - MarketBeat
5 Must-Read Analyst Questions From Amgen’s Q1 Earnings Call - The Globe and Mail
Amgen’s US$300m Biologics Push And What It Means For AMGN Stock - Yahoo Finance
Stevens Capital Management LP Invests $1.16 Million in Amgen Inc. $AMGN - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.04%
2.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):